cyclosporine and Sicca Syndrome

cyclosporine has been researched along with Sicca Syndrome in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (23.73)	18.2507
2000's	13 (22.03)	29.6817
2010's	22 (37.29)	24.3611
2020's	10 (16.95)	2.80

Authors

Authors	Studies
Choi, M; Edman, MC; Guo, H; Hamm-Alvarez, SF; Ju, Y; Louie, SG; MacKay, JA	1
Gao, M; Kong, X; Liang, R; Zhao, L; Zhao, Q; Zhu, Q	1
Geyer, HL; Juthani, V; Kitsis, EA; Napier, F	1
Bombardieri, S; Bootsma, H; Bowman, S; Brito-Zerón, P; De Vita, S; Dörner, T; Fisher, BA; Gottenberg, JE; Hernandez-Molina, G; Kocher, A; Kostov, B; Kruize, AA; Mandl, T; Mariette, X; Ng, WF; Ramos-Casals, M; Retamozo, S; Seror, R; Shoenfeld, Y; Sisó-Almirall, A; Tzioufas, AG; Vitali, C	1
Cubuk, MO; Ozgur, A; Ozulken, K; Ucgul, AY; Yuksel, E	1
El Zawahry, O; Hassanein, D; Moawad, P; Ragab, G; Shamma, R	1
Baldini, C; Bootsma, H; Bowman, SJ; Brito-Zerón, P; De Vita, S; Dörner, T; Fisher, BA; Gottenberg, JE; Hernández-Molina, G; Kocher, A; Kostov, B; Kruize, AA; Mandl, T; Mariette, X; Ng, WF; Ramos-Casals, M; Retamozo, S; Seror, R; Shoenfeld, Y; Sisó-Almirall, A; Tzioufas, AG; Vissink, A; Vitali, C	1
Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV	1
Min, SN; Yu, GY; Zhu, YY	1
Ji, YS; Kim, J; Moon, TK; Yoon, HJ; Yoon, KC	1
Asbell, PA; Kuklinski, E	1
Boujnah, Y; Burillon, C; Dot, C; El-Chehab, H; Kocaba, V; Mouchel, R	1
Edman, MC; Guo, H; Hamm-Alvarez, SF; Janga, SR; Klinngam, W; Lee, C; MacKay, JA; Shah, M	1
Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ	1
Cheon, EJ; Chou, M; Chung, SH; Hwang, J; Kang, MJ; Kim, YH; Lee, HJ	1
Davis, RM; Grubbs, J; Huynh, K; Liu, KC	1
Devecı, H; Kobak, S	1
Matsuzaki, H; Nakagawa, H; Nobeyama, Y	1
Gong, L; Lin, T	1
Deng, Z; He, A; Li, S; Liu, L; Shi, L; Wang, K; Yu, Z	1
Ciurtin, C; Cojocaru, VM; Isenberg, DA; Ostas, A; Walsh, SB	1
Acharya, NR; Cuddapah, PA; Lietman, TM; Liu, MP; O'Brien, KS; Rose-Nussbaumer, J; Sy, A	1
Burmester, GR; Callhoff, J; Feist, E; Gamboa, LM; Hagemann, A; Kedor, C; Zernicke, J	1
Chighizola, CB; Meroni, PL; Ong, VH	1
Fujikawa, K; Harada, K; Ito, M; Iwanaga, N; Izumi, Y; Kawahara, C; Kawakami, A; Kurohama, K; Migita, K; Tsuji, Y; Yoshida, S	1
Baudouin, C; Borderie, V; Bouheraoua, N; Dupas, B; Hamiche, T; Labbé, A; Laroche, L; Levy, O	1
Foulks, GN	1
Akpek, EK; Shan, SJ; Wu, EI	1
Dana, R; Dastjerdi, MH; Hamrah, P	1
Fujisawa, T; Seishima, M	1
Aksu, K; Emmungil, H; Kalfa, M; Karabulut, G; Keser, G; Sen, S; Zihni, FY	1
Borda, A; Horvath, K; Máté-István, I; Vultur, F	1
Kiss, CG; Kiss, E; Poór, G	1
Ichinose, A; Ieko, M; Inoue, M; Kasahara, Y; Kurita, T; Majima, T; Matsuoka, M; Onodera, T; Souri, M; Takahashi, D	1
Bové, A; Brito-Zerón, P; Kostov, BA; Ramos-Casals, M; Sisó-Almirall, A	1
Auw-Hädrich, C; Mittelviefhaus, H	1
Baudouin, C; Brignole, F; Galatoire, O; Pisella, PJ	1
Fujii, A; Hara, S; Hosino, J; Katori, H; Murata, H; Nishi, T; Sawa, N; Shibata, S; Tagami, T; Takaichi, K; Takemoto, F; Ubara, Y; Yokota, M	1
Baudouin, C; Brignole, F; Pisella, PJ	1
Kujawa, A; Rózycki, R	2
Gause, A	1
Hyon, JY; Lee, YJ; Yun, PY	1
Gündüz, K; Ozdemir, O	1
Nasonov, EL; Nasonova, VA; Shtutman, VZ	1
Fernández, F; García Sánchez, J; Márquez, M; Rubio Pérez, P; Sánchez Sánchez, ML; Terrancle Juan, F; Zaragoza, P	1
Lewandowska-Furmanik, M; Misztal, S; Toczołowski, J	1
Collum, LM; Farrell, M; Mullaney, P; Power, WJ	1
Burek, CL; Jabs, DA; Lee, B; Prendergast, RA; Saboori, AM	1
Hashimoto, H; Hirose, S; Hishikawa, T; Iida, N; Kaneko, H; Murashima, A; Ogasawara, H; Sekigawa, I; Tokano, Y	1
Hashimoto, H; Hirose, S; Hishikawa, T; Iida, N; Murashima, A; Ogasawara, H; Sekigawa, I; Sekiya, M; Tokano, Y	1
Hayashi, Y; Ishimaru, N; Saito, I; Tsubota, K	1
Irimajiri, J; Kimura, K; Nishioka, K; Yamamoto, T; Yokozeki, H	1
Hashimoto, H; Hirose, S; Iida, N; Sekigawa, I; Sugiyama, M; Tokano, Y	1
Anlauf, M; Hartung, K; Helmchen, U; Tholl, U	1
Fujita, H; Hayashi, Y; Murakami, T; Saito, I; Tadano, K; Takeuchi, T; Tsubota, K	1
Fukumura, A; Karasawa, H; Kawabata, H; Kim, CG; Masaki, Y; Ogawa, N; Okada, J; Simoyama, K; Sugai, S; Wano, Y	1
Feutren, G; Mihatsch, MJ	1
Kashiwagi, H	1

Reviews

12 review(s) available for cyclosporine and Sicca Syndrome

Article	Year
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's Syndrome. Drugs & aging, 2021, Volume: 38, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Rheumatic Diseases; Sjogren's Syndrome	2021
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature. Rheumatology (Oxford, England), 2022, 03-02, Volume: 61, Issue:3 Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome	2022
Sjogren's syndrome from the perspective of ophthalmology. Clinical immunology (Orlando, Fla.), 2017, Volume: 182 Topics: Administration, Ophthalmic; Cyclosporine; Dry Eye Syndromes; Fatty Acids, Omega-3; Glucocorticoids; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Muscarinic Agonists; Ophthalmology; Phenylalanine; Pilocarpine; Punctal Plugs; Quinuclidines; Sjogren's Syndrome; Sulfones; Thiophenes	2017
Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca. Current allergy and asthma reports, 2014, Volume: 14, Issue:1 Topics: Animals; Antigen-Presenting Cells; Apoptosis; Autoantibodies; Autoimmunity; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunity, Cellular; Immunity, Humoral; Keratoconjunctivitis Sicca; Molecular Mimicry; Quinuclidines; Sjogren's Syndrome; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thiophenes	2014
Advances in the treatment of ocular dryness associated with Sjögren׳s syndrome. Seminars in arthritis and rheumatism, 2015, Volume: 45, Issue:3 Topics: Anti-Inflammatory Agents; Cyclosporine; Dry Eye Syndromes; Humans; Lubricant Eye Drops; Sjogren's Syndrome; Treatment Outcome	2015
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review. Clinical reviews in allergy & immunology, 2017, Volume: 52, Issue:3 Topics: Adult; Arthritis, Juvenile; Behcet Syndrome; Child; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Rheumatology; Sjogren's Syndrome; Still's Disease, Adult-Onset; T-Lymphocytes; Virus Replication	2017
Treatment of dry eye disease by the non-ophthalmologist. Rheumatic diseases clinics of North America, 2008, Volume: 34, Issue:4 Topics: Administration, Topical; Anti-Inflammatory Agents; Cyclosporine; Dry Eye Syndromes; Female; Humans; Lubricants; Male; Ophthalmic Solutions; Rheumatology; Risk Factors; Sjogren's Syndrome; Water-Electrolyte Balance	2008
[The treatment of secondary Sjogren syndrome]. Oftalmologia (Bucharest, Romania : 1990), 2010, Volume: 54, Issue:4 Topics: Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Early Diagnosis; Gels; Humans; Immunologic Factors; Immunosuppressive Agents; Ointments; Ophthalmic Solutions; Prognosis; Rituximab; Sjogren's Syndrome; Treatment Outcome; Vitamin A; Vitamins	2010
[Systemic autoimmune disorders and pregnancy]. Orvosi hetilap, 2011, Oct-23, Volume: 152, Issue:43 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha	2011
Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:3 Topics: Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Molecular Targeted Therapy; Ophthalmic Solutions; Saliva, Artificial; Sjogren's Syndrome	2013
[Current treatments of xerophthalmia in Sjögren's syndrome]. La Revue de medecine interne, 2004, Volume: 25, Issue:5 Topics: Administration, Topical; Anti-Infective Agents, Local; Cyclosporine; Gels; Humans; Immunosuppressive Agents; Miotics; Ophthalmic Solutions; Pilocarpine; Product Packaging; Sjogren's Syndrome; Xerophthalmia	2004
[Prospects of the use of cyclosporin A in rheumatic diseases]. Klinicheskaia meditsina, 1994, Volume: 72, Issue:5 Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome	1994

Trials

9 trial(s) available for cyclosporine and Sicca Syndrome

Article	Year
Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome. Ocular immunology and inflammation, 2023, Volume: 31, Issue:8 Topics: Cyclosporine; Dry Eye Syndromes; Humans; Lubricant Eye Drops; Ophthalmic Solutions; Sjogren's Syndrome; Tears	2023
Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome. European journal of ophthalmology, 2022, Volume: 32, Issue:1 Topics: Cyclosporine; Dry Eye Syndromes; Humans; Lubricant Eye Drops; Ophthalmic Solutions; Prospective Studies; Sjogren's Syndrome; Tacrolimus; Tears	2022
[Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome]. Journal francais d'ophtalmologie, 2018, Volume: 41, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Dry Eye Syndromes; Eye Diseases; Female; Humans; Lubricant Eye Drops; Male; Middle Aged; Patient Compliance; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Tears; Treatment Outcome; Young Adult	2018
Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren's Syndrome Dry Eye. Ocular immunology and inflammation, 2020, Apr-02, Volume: 28, Issue:3 Topics: Administration, Topical; Cell Count; Conjunctiva; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Emulsions; Female; Follow-Up Studies; Goblet Cells; Humans; Middle Aged; Nanoparticles; Prospective Studies; Sjogren's Syndrome; Treatment Outcome	2020
Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China. Medicine, 2015, Volume: 94, Issue:7 Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; China; Cyclosporine; Female; Fluorescein; Fluorometholone; Humans; Hyaluronic Acid; Male; Middle Aged; Ophthalmic Solutions; Sjogren's Syndrome; Viscosupplements	2015
A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome. Clinical rheumatology, 2016, Volume: 35, Issue:9 Topics: Adult; Aged; Antirheumatic Agents; Arthrography; Cyclosporine; Female; Humans; Joints; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome	2016
[Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression]. Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Cyclosporine; Double-Blind Method; Emulsions; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; HLA-DR Antigens; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Ophthalmic Solutions; Pharmaceutical Vehicles; Prospective Studies; Sjogren's Syndrome; Treatment Outcome	2003
[Immunological phenomenons in the pathology of the tear film. Is cyclosporine the turn point in the Sjögren's syndrome treatment? Preliminary report]. Klinika oczna, 2004, Volume: 106, Issue:3 Suppl Topics: Cyclosporine; Drug Administration Schedule; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Sjogren's Syndrome; Tears	2004
Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta ophthalmologica, 1994, Volume: 72, Issue:4 Topics: Administration, Topical; Cyclosporine; Double-Blind Method; Epithelium; Female; Humans; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Male; Middle Aged; Ophthalmic Solutions; Rose Bengal; Sjogren's Syndrome; Tears	1994

Other Studies

38 other study(ies) available for cyclosporine and Sicca Syndrome

Article	Year
Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome. Biomaterials, 2022, Volume: 283 Topics: Animals; Autoimmunity; Cyclosporine; Disease Models, Animal; Lacrimal Apparatus; Male; Mice; Mice, Inbred NOD; Sjogren's Syndrome	2022
Association of Sjögren's syndrome with myotonic dystrophy type 1. BMJ case reports, 2019, Aug-28, Volume: 12, Issue:8 Topics: Antibodies, Antinuclear; Cyclosporine; Diagnosis, Differential; Electromyography; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Middle Aged; Myotonic Dystrophy; Myotonin-Protein Kinase; Protein Kinases; Sjogren's Syndrome; Treatment Outcome	2019
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:1 Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lubricant Eye Drops; Muscarinic Agonists; Saliva, Artificial; Sjogren's Syndrome	2020
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome. International ophthalmology, 2021, Volume: 41, Issue:4 Topics: Cyclosporine; Dry Eye Syndromes; Humans; Retrospective Studies; Sjogren's Syndrome; Tears	2021
[Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2021, Aug-18, Volume: 53, Issue:4 Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Inflammation; Mice; Mice, Inbred NOD; Saliva; Sjogren's Syndrome; Submandibular Gland	2021
Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2021, Volume: 37, Issue:8 Topics: Administration, Ophthalmic; Anions; Cations; Cyclosporine; Drug Substitution; Emulsions; Female; Fluorophotometry; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Sjogren's Syndrome; Surveys and Questionnaires; Tears; Treatment Outcome	2021
A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. Journal of controlled release : official journal of the Controlled Release Society, 2018, 12-28, Volume: 292 Topics: Animals; Cyclophilin A; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Liberation; Elastin; HeLa Cells; Humans; Immunosuppressive Agents; Interleukin-2; Jurkat Cells; Male; Mice, Inbred BALB C; Mice, Inbred NOD; NFATC Transcription Factors; Peptides; Sjogren's Syndrome; Tears	2018
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy. BMC ophthalmology, 2019, Feb-14, Volume: 19, Issue:1 Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid	2019
The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome. International ophthalmology, 2014, Volume: 34, Issue:5 Topics: Administration, Topical; Adult; Case-Control Studies; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Sjogren's Syndrome	2014
Annular erythema of Sjögren's syndrome treated successfully with low-dose cyclosporine. The Journal of dermatology, 2014, Volume: 41, Issue:5 Topics: Adult; Cyclosporine; Erythema; Female; Humans; Immunosuppressive Agents; Sjogren's Syndrome; Skin Diseases, Genetic	2014
Cyclosporine A Suppresses the Activation of the Th17 Cells in Patients with Primary Sjögren's Syndrome. Iranian journal of allergy, asthma, and immunology, 2015, Volume: 14, Issue:2 Topics: Adult; Cells, Cultured; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interleukin-17; Lymphocyte Activation; Male; Nuclear Receptor Subfamily 1, Group F, Member 3; Real-Time Polymerase Chain Reaction; Sjogren's Syndrome; Th17 Cells	2015
Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). BMC ophthalmology, 2015, Oct-13, Volume: 15 Topics: Anti-Allergic Agents; Aqueous Humor; Cyclosporine; Doxycycline; Expert Testimony; Flax; Fluorometholone; Glucocorticoids; Health Care Surveys; Humans; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Loteprednol Etabonate; Practice Patterns, Physicians'; Prosthesis Implantation; Serum; Sjogren's Syndrome	2015
TAFRO syndrome with primary Sjogren's syndrome. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2016, Volume: 39, Issue:5 Topics: Adult; Bacterial Infections; Bone Marrow; Cyclosporine; Edema; Female; Fever; Fibrosis; Humans; Lymph Nodes; Lymphadenitis; POEMS Syndrome; Reticulin; Sjogren's Syndrome; Syndrome; Thrombocytopenia; Treatment Outcome	2016
Increased corneal sub-basal nerve density in patients with Sjögren syndrome treated with topical cyclosporine A. Clinical & experimental ophthalmology, 2017, Volume: 45, Issue:5 Topics: Administration, Topical; Cell Count; Cornea; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Immunosuppressive Agents; Microscopy, Confocal; Nerve Fibers; Ophthalmic Nerve; Prospective Studies; Sensation; Sjogren's Syndrome	2017
Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjogren syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:2 Topics: Aged, 80 and over; Corneal Diseases; Corneal Transplantation; Cyclosporine; Descemet Membrane; Drug Therapy, Combination; Endothelium, Corneal; Fuchs' Endothelial Dystrophy; Humans; Male; Methotrexate; Postoperative Complications; Prednisone; Sjogren's Syndrome	2009
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. Cornea, 2009, Volume: 28, Issue:10 Topics: Administration, Topical; Adult; Aged; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein; Fluorescent Dyes; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retreatment; Retrospective Studies; Severity of Illness Index; Sjogren's Syndrome; Staining and Labeling; Xerophthalmia	2009
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome. Modern rheumatology, 2010, Volume: 20, Issue:4 Topics: Adult; Cyclosporine; Glucocorticoids; Histiocytoma, Malignant Fibrous; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Prednisone; Sjogren's Syndrome; Skin Neoplasms	2010
Interstitial cystitis: a rare manifestation of primary Sjögren's syndrome, successfully treated with low dose cyclosporine. Rheumatology international, 2012, Volume: 32, Issue:5 Topics: Adult; Biopsy; Chronic Disease; Cyclosporine; Cystitis, Interstitial; Cystoscopy; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Prednisone; Sjogren's Syndrome; Treatment Outcome	2012
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis. International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Cyclosporine; Down-Regulation; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hematoma; Humans; Immunosuppressive Agents; Interleukin-6; Male; Methotrexate; Methylprednisolone; Middle Aged; Postoperative Complications; Sjogren's Syndrome	2012
[Corneal complications after hematopoietic stem cell transplantation]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:3 Topics: Adolescent; Adult; Aged; Child; Conjunctiva; Corneal Ulcer; Cyclosporine; Diagnosis, Differential; Dry Eye Syndromes; Female; Graft vs Host Reaction; Hematopoietic Stem Cell Transplantation; Humans; Lacrimal Apparatus; Limbus Corneae; Male; Middle Aged; Retrospective Studies; Sjogren's Syndrome	2003
Severe interstitial cystitis associated with Sjögren's syndrome. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:3 Topics: Cyclosporine; Cystitis, Interstitial; Female; Glucocorticoids; Humans; Hydronephrosis; Immunosuppressive Agents; Middle Aged; Prednisolone; Salivary Glands, Minor; Sjogren's Syndrome; Tomography, X-Ray Computed; Urinary Catheterization	2004
[A 0,05% cyclosporine treatment of the advanced dry eye syndrome]. Klinika oczna, 2005, Volume: 107, Issue:4-6 Topics: Administration, Topical; Bone Marrow Transplantation; Cyclosporine; Dry Eye Syndromes; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Sjogren's Syndrome; Time Factors; Treatment Outcome	2005
[Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Recommendations for supportive therapy for Sjögren's syndrome]. Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:1 Topics: Bromhexine; Cyclosporine; Dry Eye Syndromes; Electric Stimulation Therapy; Expectorants; Humans; Muscarinic Antagonists; Ophthalmic Solutions; Pilocarpine; Quinuclidines; Sjogren's Syndrome; Thiophenes; Xerostomia	2007
Management of ocular surface inflammation in Sjögren syndrome. Cornea, 2007, Volume: 26, Issue:9 Suppl 1 Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Sjogren's Syndrome; Treatment Outcome	2007
[The preliminary results of treatment with cyclosporin A (Sandimmun) in patients with primary Sjögren's syndrome]. Anales de medicina interna (Madrid, Spain : 1984), 1994, Volume: 11, Issue:1 Topics: Cyclosporine; Drug Evaluation; Female; Humans; Remission Induction; Sjogren's Syndrome	1994
[Local use of cyclosporin in nonbacterial corneal ulceration]. Klinika oczna, 1993, Volume: 95, Issue:5 Topics: Anti-Infective Agents, Local; Corneal Transplantation; Corneal Ulcer; Cyclosporine; Female; Humans; Middle Aged; Rheumatic Diseases; Sjogren's Syndrome	1993
Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome. Cornea, 1993, Volume: 12, Issue:6 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Conjunctiva; Cyclosporine; Female; Humans; Leukocyte Count; Male; Middle Aged; Ophthalmic Solutions; Sjogren's Syndrome; T-Lymphocyte Subsets; Xerophthalmia	1993
Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice. Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:2 Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; Choroiditis; Cyclosporine; DNA; Enzyme-Linked Immunosorbent Assay; Female; Glomerulonephritis; Immunoglobulin G; Immunosuppressive Agents; Injections, Intraperitoneal; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lymph Nodes; Mice; Mice, Mutant Strains; Scleritis; Sjogren's Syndrome	1996
Effect of low-dose cyclosporin treatment on interstitial pneumonitis associated with Sjögren's syndrome. British journal of rheumatology, 1998, Volume: 37, Issue:3 Topics: Antirheumatic Agents; Cyclosporine; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Sjogren's Syndrome	1998
Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjögren's syndrome. Clinical rheumatology, 1998, Volume: 17, Issue:2 Topics: Cyclosporine; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Sjogren's Syndrome; Tomography, X-Ray Computed	1998
Use of topical cyclosporin A in a primary Sjögren's syndrome mouse model. Investigative ophthalmology & visual science, 1998, Volume: 39, Issue:9 Topics: Administration, Oral; Administration, Topical; Animals; CD4-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; DNA Primers; Female; Flow Cytometry; Hyaluronan Receptors; Immunoenzyme Techniques; Immunosuppressive Agents; Interleukin-2; Lacrimal Apparatus; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Ophthalmic Solutions; Polymerase Chain Reaction; Receptors, Antigen, T-Cell, alpha-beta; RNA, Messenger; Sjogren's Syndrome; Submandibular Gland	1998
Verruca vulgaris developing during cyclosporin therapy for psoriasis vulgaris. The Journal of dermatology, 1998, Volume: 25, Issue:10 Topics: Cyclosporine; Drug Administration Schedule; Facial Dermatoses; Humans; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Sjogren's Syndrome; Skin Diseases; Warts	1998
Effective treatment of autoimmune diseases with extremely low dose cyclosporine. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1998, Volume: 21, Issue:1 Topics: Adult; Autoimmune Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Middle Aged; Sjogren's Syndrome; Thrombocytopenia	1998
[Primary Sjögren's syndrome and glomerulonephritis]. Deutsche medizinische Wochenschrift (1946), 1998, Dec-18, Volume: 123, Issue:51-52 Topics: Aged; Aged, 80 and over; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Hemofiltration; HLA-DR3 Antigen; Humans; Immunosuppressive Agents; Kidney; Nephrotic Syndrome; Prednisolone; Sjogren's Syndrome	1998
Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:1 Topics: Administration, Topical; Animals; Apoptosis; Chemotaxis, Leukocyte; Cyclosporine; Disease Models, Animal; Fas Ligand Protein; Female; Fluorescent Antibody Technique, Indirect; Immunosuppressive Agents; Lacrimal Apparatus; Lymphocytes; Male; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, Transgenic; Ophthalmic Solutions; Sjogren's Syndrome; Tears	2001
[A case of Sjögren's syndrome with dermatomyositis who died of rapidly progressive interstitial pneumonia]. Ryumachi. [Rheumatism], 2001, Volume: 41, Issue:1 Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome	2001
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25 Topics: Adolescent; Adult; Age Factors; Autoimmune Diseases; Blood Pressure; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Psoriasis; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Uveitis	1992
[Decision on therapeutic course and follow-up study of collagen diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Nov-10, Volume: 80, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aortic Arch Syndromes; Behcet Syndrome; Collagen Diseases; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Methylprednisolone; Mixed Connective Tissue Disease; Sjogren's Syndrome	1991